Promising Results of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Perihilar Cholangiocarcinoma in a Systematic Review and Single-Arm Meta-Analysis
Cancers · 13.02.2024 · 16 (4) · 771
DOI: 10.3390/cancers16040771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.02.2024. Verfasst von Mohammad Golriz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
ALPPS popularity is increasing among surgeons worldwide and its indications are expanding to cure patients with primarily unresectable liver tumors. Few reports recommended limitations or even contraindications of ALPPS in perihilar cholangiocarcinoma (phCC). Here, we discuss the results of ALPPS in patients with phCC in a systematic review as well as a pooled data analysis.
Methods
MEDLINE and Web of Science databases were systematically searched for relevant literature up to December 2023. All studies reporting ALPPS in the management of phCC were included. A single-arm meta-analysis of proportions was carried out to estimate the overall rate of outcomes.
Results
After obtaining 207 articles from the primary search, data of 18 studies containing 112 phCC patients were included in our systematic review. Rates of major morbidity and mortality were calculated to be 43% and 22%, respectively. The meta-analysis revealed a PHLF rate of 23%. One-year disease-free survival was 65% and one-year overall survival was 69%.
Conclusions
ALPPS provides a good chance of cure for patients with phCC in comparison to alternative treatment options, but at the expense of debatable morbidity and mortality. With refinement of the surgical technique and better perioperative patient management, the results of ALPPS in patients with phCC were improved.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany.
- Liver Cancer Centre Heidelberg (LCCH), University Hospital Heidelberg, 69120 Heidelberg, Germany.
- Clinic of General and Visceral Surgery, Diakonie in Südwestfallen, 57076 Siegen, Germany.
- Digestive Oncology Unit, Champalimaud Foundation, 1400-038 Lisbon, Portugal.
- Department of Radiology, Champalimaud Foundation, 1400-038 Lisbon, Portugal.
- Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
ORCID-Profile: Mohammad Golriz
Zitieren
APA
Golriz, M., Ramouz, A., Hammad, A., Aminizadeh, E., Sabetkish, N., Khajeh, E., Ghamarnejad, O., Carvalho, C., Rio-Tinto, H., Chang, D. H., Joao, A. A., Goncalves, G., & Mehrabi, A. (2024). Promising Results of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Perihilar Cholangiocarcinoma in a Systematic Review and Single-Arm Meta-Analysis. Cancers, 16(4), 771. https://doi.org/10.3390/cancers16040771
Vancouver
Golriz M, Ramouz A, Hammad A, Aminizadeh E, Sabetkish N, Khajeh E, et al. Promising Results of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Perihilar Cholangiocarcinoma in a Systematic Review and Single-Arm Meta-Analysis. Cancers. 2024;16(4):771. doi:10.3390/cancers16040771
BibTeX
@article{Golriz2024,
author = {Golriz, Mohammad and Ramouz, Ali and Hammad, Ahmed and Aminizadeh, Ehsan and Sabetkish, Nastaran and Khajeh, Elias and Ghamarnejad, Omid and Carvalho, Carlos and Rio-Tinto, Hugo and Chang, De-Hua and Joao, Ana Alagoa and Goncalves, Gil and Mehrabi, Arianeb},
title = {Promising Results of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Perihilar Cholangiocarcinoma in a Systematic Review and Single-Arm Meta-Analysis},
journal = {Cancers},
year = {2024},
volume = {16},
number = {4},
pages = {771},
doi = {10.3390/cancers16040771}
}
EUVIMED